Therapeutics Update New products and pharmacologic developments Therapeutics Focus: Lasers

Lumenis Offers new LightSheer Desire Syneron’s me Brand Now FDA Cleared for The Lumenis LightSheer 800nm diode laser technology Permanent Reduction in Hair Growth offers excellent results, maximum safety and comfort, and The FDA has granted Syneron Medical Ltd. and Iluminage was recognized as the gold standard for laser hair removal Beauty an expanded indication for the me brand of home-use with more than 50 peer-reviewed articles documenting hair removal systems. The systems, which utilize Syneron’s its efficacy, safety, and patient satisfaction, according to proprietary elos technology, are now indicated for permanent Lumenis. The company is now offering the LightSheer Desire reduction in hair growth. The me brand is owned and sold as a table-top model. It offers high-speed vacuum assisted by Iluminage Beauty, Syneron’s global joint venture in home capabilities and precision. The LightSheer’s 800nm wave- beauty devices. length offers the optimal wavelength for safely and effec- Shimon Eckhouse, Chief Executive Officer of Syneron Medical, tively treating all skin types. With the LightSheer technol- said, “The additional indication for permanent reduction in hair ogy, treatment can be tailored to each patient to offer the growth for the me home-use hair removal system is another unique solution needed through a combination of efficacy, positive milestone in the application of our proprietary elos safety, comfort, speed, and accuracy. The technology offers technology in the home-use market. It builds on its position as high peak-power, adjustable pulse duration, and variety of the first and only FDA cleared consumer hair removal technol- spot-sizes to treat all body areas in the shortest time. Its ogy that is approved for all skin tones, further differentiating it high-speed technology treatment time is reduced by 75 per- from the competition.” cent, which allows physicians to treat more patients in the same amount of time, attract more patients due to treat- FDA-Approved OTC Theradome Laser ment speed, comfort and affordability, resulting in increasing Therapy Helmet Launches the practice revenue potential. Theradome, developers of the first clinical-level laser hair restoration product, recently launced the Theradome Laser Alma Lasers Introduces SopranoICE Helmet LH80 PRO, the first over-the-counter, FDA-cleared, The new SopranoICE from Alma Lasers incorporates multiple wearable laser hair restoration treatment. The light-based cooling mechanisms to maximize a patient’s comfort during medical treatment was developed for the convenience of in- laser hair removal procedures. According to the company, the home use and is clinically tested, and designed for patients device uses Speed Technology to deliver optimal results in half suffering from the debilitating effects of thinning hair and the time, a benefit for physicians and patients. androgenetic alopecia. Theradome Laser Helmet LH80 PRO The SopranoICE, an 810nm diode laser for painless perma- is a compact, cordless, easy-to-use, OTC helmet that utilizes nent hair removal, is FDA cleared for the treatment of skin proven laser light therapy used at dermatology offices and types I-VI and tanned skin and is safe to treat patients year hair restoration clinics to grow new healthy hair, while dou- round. The SopranoICE builds on the company’s Super Hair bling the hair follicle size of existing hair and slowing down or Removal (SHR) technology. Its Speed Technology gives opera- stopping hair loss. tors the ability to treat at 10 hertz per second. This speed, cou- Using 80 lasers that provide more than 560 mW of low pled with a lightweight handpiece, effectively enhances results laser light therapy (LLLT), the helmet stimulates the scalp and by eliminating the traditional lengthy hair removal treatments hair follicles in a state of decline by increasing blood flow and and reduces user fatigue. The gradual heating SHR technique microcirculation, improving cellular metabolism and protein creates a comfortable treatment experience without analgesics. synthesis to restore and maintain a healthy head of hair. The Other benefits include an intuitive and user-friendly 12” Theradome Laser Helmet LH80 PRO maximizes human hair color touch screen with pre-set parameters, cooler treatment, growth when used twice a week for 20 minutes per session. reduced applicator weight, and no consumables. Theradome Laser Helmet LH80 PRO underwent clinical tri- SopranoICE includes an added patient benefit of the als that found that after 18 treatments, hair loss slows down, ClearTite treatment. ClearTite’s deep dermal heating provides after 26 treatments, patients experience healthier hair and patients with temporary relief of minor muscle aches and pains. scalp, after 52 treatments there is new hair growth (of vari- The NIR body and face modules for temporary relief of muscle ous percentages for each patient), and after 100 treatments, aches and pains and deep dermal heating offer additional rev- patients have fuller, thicker hair and no additional hair loss enue streams. with continued use.

48 PRACTICAL DERMATOLOGY january 2014 Therapeutics Update New Products

AcneFree Body Clearing Acne Spray Valeant’s AcneFree’s new Body Clearing Acne Spray is a clear, quick-drying spray that delivers acne medication to hard-to-reach places on the body. The spray features a lightweight, oil- free formula with 2% salicylic acid to help treat and prevent breakouts. The non-stick formula also includes vitamin B3 (niacina- mide) to help the skin produce more nat- ural ceramides, glycolic acid to help exfoli- ate skin, and aloe and other plant and root extracts to soothe the skin and even skin tone. Patients can spray continuously at any angle, helping to ensure that effective ingredients reach areas such as the back and shoulders. AcneFree Body Clearing Acne Spray will be available starting February 2014. acnefree.com

Scar MD Gel and Spray Available Scar MD Silicone Scar Gel and Spray are unique formulations of silicone that dry to form an ultra-thin layer on the skin that provides a semi-occlusive barrier, with similar breathability to the skin. This modifies the factors involved in heal- ing to normalize the production of collagen, which in turn reduces the redness of abnormal scars, decreases their volume, and reduces the pain and itchiness. Company data show that patients’ scars improve with treatment over a two- to three-month period by up to 80 per- cent, as measured by patient satisfaction. Scar MD Scar Gel and Spray are clinically proven to reduce redness, reduce itching, reduce pain, soften scar tissue, flatten raised scars, and pre- vent abnormal scarring. scarmd.net

Glytone By Ducray The new Glytone by Ducray hair loss range is formulated to target factors that influence healthy hair growth for both occasional and chronic hair thinning/loss. The line includes the Anaphase Cream Shampoo to nourish and strengthen weak, thinning hair, and to prepare the scalp for hair loss treatments, the Neoptide Hair Lotion Spray, a revitalizing formula for devi- talized hair and chronic hair loss in women, and the Anastim Hair Lotion Concentrate, a nourishing formula for devitalized hair and occasional hair loss. The line also includes the Glytone By Ducray Anacaps Dietary Supplement. Glytone-usa.com n

january 2014 PRACTICAL DERMATOLOGY 49